| 1 | SETBP1, TRIM29, VEZF1
|
| TRIM29 regulates the SETBP1/SET/PP2A axis via transcription factor VEZF1 to promote progression of ovarian cancer
|
| Qiao HY, Zhang Q, Wang JM, Jiang JY, Huyan LY, Yan J, Li C, Wang HQ.
|
| Cancer Lett. Mar 31;529:85-99. doi: 10.1016/j.canlet.2021.12.029. Epub 2021 Dec 29. 2022
|
| 2 | TRIM29
|
| Clinical significance of TRIM29 expression in patients with gastric cancer.
|
| Farhadi J, Mehrzad J, Mehrad-Majd H, Motavalizadehkakhky A.
|
| Spring Gastroenterol Hepatol Bed Bench 15(2):131-138 2022
|
| 3 | FAM83H, TRIM29
|
| TRIM29 in Cutaneous Squamous Cell Carcinoma
|
| Hsu CY, Yanagi T, Ujiie H.
|
| Front Med (Lausanne). Dec 20;8:804166. doi: 10.3389/fmed.2021.804166. 2021
|
| 4 | KLF4, TRIM29
|
| KLF4 transactivates TRIM29 expression and modulates keratin network
|
| Huang R, Fu Y, Deng Y.
|
| Biochem Biophys Rep. Aug 27;28:101117. doi: 10.1016/j.bbrep.2021.101117. 2021
|
| 5 | TP53BP1, TRIM29
|
| TRIM29 is required for efficient recruitment of 53BP1 in response to DNA double-strand breaks in vertebrate cells
|
| Wikiniyadhanee R, Lerksuthirat T, Stitchantrakul W, Chitphuk S, Sura T, Dejsuphong D.
|
| FEBS Open Bio Oct;10(10):2055-2071. doi: 10.1002/2211-5463.12954. Epub 2020 Aug 31. 2020
|
| 6 | TRIM29
|
| Identification of the E3 Ligase TRIM29 as a Critical Checkpoint Regulator of NK Cell Functions.
|
| Dou Y, Xing J, Kong G, Wang G, Lou X, Xiao X, Vivier E, Li XC, Zhang Z.
|
| J Immunol. Aug 15;203(4):873-880. doi: 10.4049/jimmunol.1900171. Epub 2019 Jul 3. 2019
|
| 7 | TRIM29
|
| TRIM29 Negatively Regulates the Type I IFN Production in Response to RNA Virus.
|
| Xing J, Zhang A, Minze LJ, Li XC, Zhang Z.
|
| J Immunol. Jul 1;201(1):183-192. doi: 10.4049/jimmunol.1701569. Epub 2018 May 16. 2018
|
| 8 | TRIM29
|
| TRIM29 promotes DNA virus infections by inhibiting innate immune response
|
| Xing J, Zhang A, Zhang H, Wang J, Li XC, Zeng MS, Zhang Z.
|
| Nat Commun. Oct 16;8(1):945. doi: 10.1038/s41467-017-00101-w 2017
|
| 9 | TRIM29
|
| TRIM29 overexpression is associated with poor prognosis and promotes tumor progression by activating Wnt/β-catenin pathway in cervical cancer
|
| Xu R, Hu J, Zhang T, Jiang C, Wang HY.
|
| Oncotarget. May 10;7(19):28579-91. doi: 10.18632/oncotarget.8686. 2016
|
| 10 | TP63, TRIM29
|
| TRIM29 regulates the p63-mediated pathway in cervical cancer cells
|
| Masuda Y, Takahashi H, Hatakeyama S.
|
| Biochim Biophys Acta. Oct;1853(10 Pt A):2296-305. doi: 10.1016/j.bbamcr.2015.05.035. Epub 2015 Jun 10. 2015
|
| 11 | TRIM29
|
| TRIM29 regulates the assembly of DNA repair proteins into damaged chromatin.
|
| Masuda Y, Takahashi H, Sato S, Tomomori-Sato C, Saraf A, Washburn MP, Florens L, Conaway RC, Conaway JW, Hatakeyama S.
|
| Nat Commun. Jun 22;6:7299. doi: 10.1038/ncomms8299. 2015
|
| 12 | TRIM29
|
| Down-regulating ATDC inhibits the proliferation of esophageal carcinoma cells
|
| Lai W, Zheng X, Huang Q, Wu X, Yang M.
|
| Eur Rev Med Pharmacol Sci. Nov;18(22):3511-6. 2014
|
| 13 | KAT5, TRIM29
|
| TRIM29 negatively regulates p53 via inhibition of Tip60.
|
| Sho T, Tsukiyama T, Sato T, Kondo T, Cheng J, Saku T, Asaka M, Hatakeyama S.
|
| Biochim Biophys Acta 1813(6):1245-53. Epub 2011 Apr 2.
2011
|
| 14 | HDAC9, TRIM29
|
| Histone deacetylase 9 (HDAC9) regulates the functions of the ATDC (TRIM29) protein.
|
| Yuan Z, Peng L, Radhakrishnan R, Seto E.
|
| J Biol Chem 285(50):39329-38. Epub 2010 Oct 14.
2010
|
| 15 | TRIM29
|
| The ATDC (TRIM29) protein binds p53 and antagonizes p53-mediated functions.
|
| Yuan Z, Villagra A, Peng L, Coppola D, Glozak M, Sotomayor EM, Chen J, Lane WS, Seto E.
|
| Mol Cell Biol 30(12):3004-15. Epub 2010 Apr 5.
2010
|
| 16 | TRIM29
|
| Oncogenic function of ATDC in pancreatic cancer through Wnt pathway activation and beta-catenin stabilization.
|
| Wang L, Heidt DG, Lee CJ, Yang H, Logsdon CD, Zhang L, Fearon ER, Ljungman M, Simeone DM.
|
| Cancer Cell ancer Cell. 2009 2009
|
| 17 | TRIM29
|
| Tripartite motif-containing 29 (TRIM29) is a novel marker for lymph node metastasis in gastric cancer.
|
| Kosaka Y, Inoue H, Ohmachi T, Yokoe T, Matsumoto T, Mimori K, Tanaka F, Watanabe M, Mori M.
|
| Ann Surg Oncol 14(9):2543-9. Epub 2007 Jun 28.
2007
|
| 18 | TRIM29
|
| Suppression of anchorage-independent growth by expression of the ataxia-telangiectasia group D complementing gene, ATDC.
|
| Hosoi Y, Kapp LN, Murnane JP, Matsumoto Y, Enomoto A, Ono T, Miyagawa K.
|
| Biochem Biophys Res Commun 348(2):728-34. Epub 2006 Jul 28.
2006
|
| 19 | LOH11CR2A, PPP2R1B, USP2, RNF26, POU2F3, TRIM29
|
| Fine mapping and evaluation of candidate genes for cervical cancer on 11q23.
|
| Zhang Z, Gerhard DS, Nguyen L, Li J, Traugott A, Huettner PC, Rader JS.
|
| Genes Chromosomes Cancer 43(1):95-103. 2005
|
| 20 | ATM, TRIM10, TRIM11, TRIM14, TRIM15, TRIM16, TRIM17, TRIM2, TRIM22, TRIM26, TRIM28, TRIM29, TRIM3, TRIM31, TRIM32, TRIM33, TRIM34, TRIM35, TRIM36, TRIM37, TRIM38, TRIM4, TRIM42, TRIM5, TRIM6, TRIM7, TRIM8, TRIM9, TRIMP1
|
| The tripartite motif family identifies cell compartments.
|
| Reymond A, Meroni G, Fantozzi A, Merla G, Cairo S, Luzi L, Riganelli D, Zanaria E, Messali S, Cainarca S, Guffanti A, Minucci S, Pelicci PG, Ballabio A.
|
| EMBO J 20(9):2140-51. 2001
|
| 21 | TRIM29
|
| Altered splicing of the ATDC message in ataxia telangiectasia group D cells results in the absence of a functional protein.
|
| Tauchi H, Green C, Knapp M, Laderoute K, Kapp L.
|
| Mutagenesis 15(2):105-8. 2000
|
| 22 | TRIM29
|
| Expression of the ATDC (ataxia telangiectasia group D-complementing) gene in A431 human squamous carcinoma cells.
|
| Laderoute KR, Knapp AM, Green CJ, Sutherland RM, Kapp LN.
|
| Int J Cancer 66(6):772-8. 1996
|
| 23 | ATM, HINT1, TRIM29
|
| The product of the ataxia-telangiectasia group D complementing gene, ATDC, interacts with a protein kinase C substrate and inhibitor.
|
| Brzoska PM, Chen H, Zhu Y, Levin NA, Disatnik MH, Mochly-Rosen D, Murnane JP, Christman MF.
|
| Proc Natl Acad Sci U S A 92(17):7824-8. 1995
|
| 24 | ATM, TRIM29
|
| A radiation hybrid map of human chromosome 11q22-q23 containing the ataxia-telangiectasia disease locus.
|
| Richard CW 3rd, Cox DR, Kapp L, Murnane J, Cornelis F, Julier C, Lathrop GM, James MR.
|
| Genomics 17(1):1-5. 1993
|